Short Information | Dyne Therapeutics Inc. (NYSE:DYN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 17,092 |
Total Actual Volume | 32,929,423 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 855 |
Average Short Percentage | 0.01% |
Is there a DYN Short Squeeze or Breakout about to happen?
See the DYN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-06-2018 | $13.12 | $12.81 | $13.18 | $12.76 | 22,175,203 | 12,074 | 0.05% |
04-05-2018 | $13.42 | $13.14 | $13.66 | $13.05 | 8,887,741 | 3,853 | 0.04% |
04-04-2018 | $13.41 | $13.37 | $13.46 | $13.255 | 1,866,479 | 1,165 | 0.06% |
News, Short Squeeze, Breakout and More Instantly...
2024-04-20 23:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that it has granted an induceme...
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage muscle disease company focused on adva...